| Lifileucel studied in …STUDIED_INderived29 of 29show fewer |
|---|
| → studied in | NCT03108495Phase 2 · terminated Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma · 29 trials list this drug (17 active) | — | — | Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05607095Phase 1 · recruiting A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma · 29 trials list this drug (17 active) | — | — | Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05640193Phase 1 · active not recruiting A Study of LN-144 in People With Metastatic Melanoma to the Brain · 29 trials list this drug (17 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05903937Phase 1 · not yet recruiting Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases · 29 trials list this drug (17 active) | — | — | Cutaneous Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07183852Phase 1 · not yet recruiting Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma · 29 trials list this drug (17 active) | — | — | Cutaneous Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06743126Phase 3 · recruiting SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma · 29 trials list this drug (17 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06473961Phase 1 · recruiting A Phase Ib Study of GC101 in NSCLC · 29 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07560111Phase 2 · recruiting A Phase II Study of GC101 in NSCLC · 29 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741877Phase 2 · not yet recruiting A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma · 29 trials list this drug (17 active) | — | — | Sarcoma,Soft Tissue Sarcoma,Dedifferentiated Liposarcoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07700121early Phase 1 · not yet recruiting PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma · 29 trials list this drug (17 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04614103Phase 2 · recruiting Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer · 29 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03645928Phase 2 · terminated Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors · 29 trials list this drug (17 active) | — | — | Melanoma,Head and Neck Squamous Cell Carcinoma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06151847Phase 2 · completed Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma · 29 trials list this drug (17 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288203Phase 2 · active not recruiting A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma · 29 trials list this drug (17 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02360579Phase 2 · completed Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma · 29 trials list this drug (17 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176470Phase 1 · active not recruiting Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients · 29 trials list this drug (17 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288073Phase 2 · recruiting TIL Therapy in cSCC and MCC · 29 trials list this drug (17 active) | — | — | Malignant Skin Neoplasm,Skin Squamous Cell Carcinoma,Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06481592Phase 2 · recruiting A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. · 29 trials list this drug (17 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04812470Phase 1 · completed Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases · 29 trials list this drug (17 active) | — | — | Cutaneous Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084299Phase 1 · recruiting Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer · 29 trials list this drug (17 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03991741Phase 1 · terminated Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors · 29 trials list this drug (17 active) | — | — | Malignant Head and Neck Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06190249Phase 1 · withdrawn Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma · 29 trials list this drug (17 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03296137Phase 1/Phase 2 · completed Adoptive Cell Therapy Across Cancer Diagnoses · 29 trials list this drug (17 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03083873Phase 2 · completed Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck · 29 trials list this drug (17 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02414945Phase 1/Phase 2 · completed TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients · 29 trials list this drug (17 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05366478Phase 1 · recruiting A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors · 29 trials list this drug (17 active) | — | — | Melanoma,Lung Non-Small Cell Carcinoma,Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05475847Phase 1 · unknown Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer · 29 trials list this drug (17 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05152797Phase 1/Phase 2 · not yet recruiting Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer · 29 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03419559Phase 2 · withdrawn Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer · 29 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |